Drug maker Sun Pharmaceutical Industries on Sunday said it is planning to enter the Japanese generics market, with drugs aimed at treating chronic diseases.
The company, which is yet to make its presence in the world's second largest drug market after the US, said it is currently evaluating options at the moment.
"Most likely we will enter the Japanese market with drugs aimed at treating chronic diseases," a spokesman said.
Asked for details, the spokesperson said: "We are evaluating...We are in the process of ascertaining as to what will be the best option for us."
The Japanese pharmaceuticals market is the second largest in the world after the US but the generics segment in the country is estimated to have an annual sales of up to USD 6 billion dollars, less than 8 per cent of the total market.
No comments:
Post a Comment